Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.
Scientists believe that medication given through the nose has the potential to be more effective because it attacks or blocks ...
Nasal drug delivery is now emerging as a promising route for the rapid delivery of certain classes of molecules.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback